Palisade Bio Files 8-K with Corporate Updates
Ticker: PALI · Form: 8-K · Filed: Dec 4, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Dec 4, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
PALISADE BIO (PBL) filed an 8-K on Dec 4th detailing corporate changes and votes. Stay tuned.
AI Summary
Palisade Bio, Inc. filed an 8-K on December 4, 2025, reporting events that occurred on December 3, 2025. The filing indicates changes to its Articles of Incorporation or Bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc., is incorporated in Delaware and based in Carlsbad, California.
Why It Matters
This 8-K filing signals significant corporate actions and potential changes for Palisade Bio, Inc., which could impact its governance, operations, and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain immediate negative financial or operational news.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- December 3, 2025 (date) — Earliest event reported
- December 4, 2025 (date) — Date of report
- Seneca Biopharma, Inc. (company) — Former company name
- Neuralstem, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Carlsbad, California (location) — Business address
FAQ
What specific amendments were made to Palisade Bio's Articles of Incorporation or Bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the excerpt.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included with this filing?
The filing mentions the inclusion of financial statements and exhibits, but their specific content is not described in the excerpt.
When was Palisade Bio, Inc. formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc.?
The company was formerly known as Seneca Biopharma, Inc. after January 27, 2020, and Neuralstem, Inc. before March 24, 2006.
What is the business address of Palisade Bio, Inc.?
The business address is 1902 Wright Place, Suite 200, Carlsbad, California, 92008.
Filing Stats: 913 words · 4 min read · ~3 pages · Grade level 11.4 · Accepted 2025-12-04 16:40:01
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 55KB
- ex3-1.htm (EX-3.1) — 14KB
- 0001493152-25-026195.txt ( ) — 237KB
- pali-20251203.xsd (EX-101.SCH) — 3KB
- pali-20251203_lab.xml (EX-101.LAB) — 33KB
- pali-20251203_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 4, 2025 Palisade Bio, Inc. By: /s/ J.D. Finley J.D. Finley Chief Executive Officer